Microfluidics chemo efficacy testing device

Rutgers University engineers have developed a microfluidics device that not only has a 95% accuracy in identifying circulating cancer cells in a liquid biopsy, it does so quickly enough for chemotherapy to begin right away.  “The idea is that a tumor biopsy is used to seed the device. Chemo agents are then added to see whether they kill the patient’s tumor cells. This is measured using a special biosensor that relies on multifrequency impedance spectroscopy to test whether a cell is alive or dead. The sensor feeds its readings into an artificial intelligence software platform that uses previously gathered knowledge to characterize each cell.”  The news piece links to a full text article.     MORE

Image Credit: Rutgers University and MedGadget.com